Michael Schmidt
Stock Analyst at Guggenheim
(4.70)
# 161
Out of 4,981 analysts
117
Total ratings
64.52%
Success rate
20.81%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Schmidt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMNM Immunome | Reiterates: Buy | $25 | $9.68 | +158.26% | 3 | Aug 25, 2025 | |
| MRSN Mersana Therapeutics | Maintains: Buy | $125 → $30 | $7.47 | +301.61% | 4 | Aug 14, 2025 | |
| ADCT ADC Therapeutics | Reiterates: Buy | $10 | $3.33 | +200.30% | 6 | Aug 13, 2025 | |
| ORIC ORIC Pharmaceuticals | Reiterates: Buy | $18 | $10.86 | +65.75% | 6 | Aug 13, 2025 | |
| CMPX Compass Therapeutics | Maintains: Buy | $10 → $12 | $3.53 | +239.94% | 5 | Aug 12, 2025 | |
| ONC BeOne Medicines AG | Maintains: Buy | $350 → $365 | $335.67 | +8.74% | 4 | Aug 7, 2025 | |
| ARVN Arvinas | Maintains: Buy | $16 → $15 | $7.81 | +92.06% | 6 | Aug 7, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $8 → $10 | $6.84 | +46.20% | 1 | Aug 6, 2025 | |
| COGT Cogent Biosciences | Reiterates: Buy | $17 | $12.81 | +32.71% | 1 | Jul 8, 2025 | |
| RVMD Revolution Medicines | Reiterates: Buy | $80 | $46.24 | +73.01% | 4 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $18.99 | +136.97% | 2 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $15 | $19.25 | -22.08% | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $52 | $46.20 | +12.55% | 1 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $10 | $4.12 | +142.72% | 1 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $16.37 | +95.48% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $9.95 | -19.60% | 2 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $109 | $69.80 | +56.16% | 5 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $1.75 | $0.05 | +3,365.35% | 3 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $9.35 | +49.73% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $92 | $86.17 | +6.77% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $33.86 | - | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $39.07 | +7.50% | 10 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $0.52 | - | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.20 | +525.00% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $1.56 | +412.82% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $36.48 | - | 3 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.27 | - | 2 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.21 | - | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.17 | - | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $8.50 | +300.00% | 4 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $0.88 | +2,167.57% | 3 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $28.61 | - | 2 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $1.61 | +1,452.80% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $4.89 | +513.50% | 1 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $6.83 | +280.67% | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.98 | - | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $80 | $36.50 | +119.18% | 5 | Feb 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.85 | - | 6 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $4 → $5.5 | $4.90 | +12.24% | 2 | Nov 7, 2017 |
Immunome
Aug 25, 2025
Reiterates: Buy
Price Target: $25
Current: $9.68
Upside: +158.26%
Mersana Therapeutics
Aug 14, 2025
Maintains: Buy
Price Target: $125 → $30
Current: $7.47
Upside: +301.61%
ADC Therapeutics
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $3.33
Upside: +200.30%
ORIC Pharmaceuticals
Aug 13, 2025
Reiterates: Buy
Price Target: $18
Current: $10.86
Upside: +65.75%
Compass Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $3.53
Upside: +239.94%
BeOne Medicines AG
Aug 7, 2025
Maintains: Buy
Price Target: $350 → $365
Current: $335.67
Upside: +8.74%
Arvinas
Aug 7, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $7.81
Upside: +92.06%
Tango Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $10
Current: $6.84
Upside: +46.20%
Cogent Biosciences
Jul 8, 2025
Reiterates: Buy
Price Target: $17
Current: $12.81
Upside: +32.71%
Revolution Medicines
Jun 25, 2025
Reiterates: Buy
Price Target: $80
Current: $46.24
Upside: +73.01%
Jun 24, 2025
Reiterates: Buy
Price Target: $45
Current: $18.99
Upside: +136.97%
May 23, 2025
Maintains: Buy
Price Target: $40 → $15
Current: $19.25
Upside: -22.08%
May 12, 2025
Reiterates: Buy
Price Target: $52
Current: $46.20
Upside: +12.55%
May 7, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $4.12
Upside: +142.72%
May 6, 2025
Reiterates: Buy
Price Target: $32
Current: $16.37
Upside: +95.48%
Apr 4, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $9.95
Upside: -19.60%
Mar 28, 2025
Reiterates: Buy
Price Target: $109
Current: $69.80
Upside: +56.16%
Mar 26, 2025
Maintains: Buy
Price Target: $3 → $1.75
Current: $0.05
Upside: +3,365.35%
Mar 24, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $9.35
Upside: +49.73%
Mar 18, 2025
Downgrades: Neutral
Price Target: $92
Current: $86.17
Upside: +6.77%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $33.86
Upside: -
Feb 12, 2025
Reiterates: Buy
Price Target: $42
Current: $39.07
Upside: +7.50%
Jan 22, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.52
Upside: -
Dec 6, 2024
Reiterates: Buy
Price Target: $20
Current: $3.20
Upside: +525.00%
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $1.56
Upside: +412.82%
Oct 7, 2024
Downgrades: Neutral
Price Target: n/a
Current: $36.48
Upside: -
May 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.27
Upside: -
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $8.21
Upside: -
Jan 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.17
Upside: -
Nov 8, 2023
Maintains: Buy
Price Target: $40 → $34
Current: $8.50
Upside: +300.00%
Jun 27, 2023
Downgrades: Neutral
Price Target: $20
Current: $0.88
Upside: +2,167.57%
Jan 3, 2022
Downgrades: Neutral
Price Target: n/a
Current: $28.61
Upside: -
Aug 10, 2021
Initiates: Buy
Price Target: $25
Current: $1.61
Upside: +1,452.80%
Jul 19, 2021
Initiates: Buy
Price Target: $30
Current: $4.89
Upside: +513.50%
May 18, 2021
Initiates: Buy
Price Target: $26
Current: $6.83
Upside: +280.67%
Apr 28, 2021
Downgrades: Neutral
Price Target: n/a
Current: $2.98
Upside: -
Feb 15, 2019
Upgrades: Outperform
Price Target: $80
Current: $36.50
Upside: +119.18%
Jan 17, 2019
Initiates: Outperform
Price Target: n/a
Current: $7.85
Upside: -
Nov 7, 2017
Maintains: Market Perform
Price Target: $4 → $5.5
Current: $4.90
Upside: +12.24%